CTRI Number |
CTRI/2025/04/086045 [Registered on: 30/04/2025] Trial Registered Prospectively |
Last Modified On: |
29/04/2025 |
Post Graduate Thesis |
Yes |
Type of Trial |
Observational |
Type of Study
|
Follow Up Study |
Study Design |
Other |
Public Title of Study
|
Incidence of Ventilator-Associated Pneumonia, it’s Clinico-Microbiological profile & Antibiotic Sensitivity Patterns in
Mechanically Ventilated ICU Patients |
Scientific Title of Study
|
Incidence of Ventilator-Associated Pneumonia, it’s Clinico-Microbiological profile & Antibiotic Sensitivity Patterns in
mechanically ventilated ICU patients - A prospective observational study. |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Puneet Goyal |
Designation |
Professor |
Affiliation |
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow |
Address |
Department of Anaesthesiology
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
Uttar Pradesh
226014
India
Lucknow UTTAR PRADESH 226014 India |
Phone |
8004904597 |
Fax |
|
Email |
princeofcoma@yahoo.co.uk |
|
Details of Contact Person Scientific Query
|
Name |
Puneet Goyal |
Designation |
Professor |
Affiliation |
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow |
Address |
Department of Anaesthesiology
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
Uttar Pradesh
226014
India
UTTAR PRADESH 226014 India |
Phone |
8004904597 |
Fax |
|
Email |
princeofcoma@yahoo.co.uk |
|
Details of Contact Person Public Query
|
Name |
Puneet Goyal |
Designation |
Professor |
Affiliation |
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow |
Address |
Department of Anaesthesiology
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
Uttar Pradesh
226014
India
UTTAR PRADESH 226014 India |
Phone |
8004904597 |
Fax |
|
Email |
princeofcoma@yahoo.co.uk |
|
Source of Monetary or Material Support
|
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
Uttar Pradesh
226014
India |
|
Primary Sponsor
|
Name |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
Address |
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Lucknow
Uttar Pradesh
226014
India |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 2 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Esha Kujur |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
Department of Anaesthesiology
Main Post op ICU
PMSSY Post op ICU
ATC ICU
SGPGI Campus
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow
Uttar Pradesh
226014
India Lucknow UTTAR PRADESH |
8884963766
esha.v.kujur@gmail.com |
Dr Puneet Goyal |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
Department of Anaesthesiology
Sanjay Gandhi Postgraduate Institute of Medical Sciences
SGPGI Campus
Lucknow
Uttar Pradesh
226014
India Lucknow UTTAR PRADESH |
8004904597
princeofcoma@yahoo.co.uk |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Comittee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: J17||Pneumonia in diseases classified elsewhere, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Nil |
Nil |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
90.00 Year(s) |
Gender |
Both |
Details |
Adult patients of both gender staying in ICU for more than 48 hours after endotracheal intubation. |
|
ExclusionCriteria |
Details |
Negative consent.
Patients admitted to ICU with ETT in situ prior admission.
Patients who are immunocompromised and or on immunosuppressant drugs.
Patients with pre-existing pneumonia, aspiration pneumonitis, ARDS, pulmonary edema and CHF.
|
|
Method of Generating Random Sequence
|
Not Applicable |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
To study the incidence of VAP and its microbiological profiling from the endotracheal isolate of mechanically ventilated ICU patients.
|
24 hours , 72 to 96 hours , after 96 hours twice weekly sampling
|
|
Secondary Outcome
|
Outcome |
TimePoints |
1.To find out the antibiotic susceptibility and sensitivity patterns of the microorganisms isolated and identified in our study.
2.To determine different risk factors in critically ill ICU patients who are on mechanical ventilator support with respect to VAP (Ventilator Associated Pneumonia).
3.To determine, difference between microbiological profile and sensitivity pattern between early and late onset Ventilator Associated Pneumonias.
|
24 hours , 72 to 96 hours , after 96 hours twice weekly sampling
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
10/05/2025 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
|
Open to Recruitment |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Type of Study: Prospective Observational Study.
Objective: To determine the incidence, clinical and microbiological profile, and antibiotic sensitivity patterns of ventilator-associated pneumonia (VAP) in ICU patients.
Background
VAP is the most common hospital acquired infection in ICU settings.
In India, gram-negative resistant organisms are increasingly responsible for VAP.
Despite growing antimicrobial resistance, VAP epidemiology in India remains underreported.
Aims and Objectives
1. Assess VAP incidence in mechanically ventilated ICU patients.
2. Analyze clinical presentation, microbiological findings, and antibiotic sensitivity.
3. Evaluate clinical response and ICU course.
Methodology
Study Setting: Three ICUs in Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI): Main Post Op ICU, Apex Trauma Centre ICU, PMSSY ICU.
Sample: Minimum of 100 adult ICU patients intubated for more than 48 hours.
Exclusions: Patients from outside SGPGI, immunocompromised, or with pre-existing lung conditions (pneumonia, ARDS, CHF).
ETT Culture Timeline: Within 24 hours of intubation.
Between 72–96 hours.
Biweekly thereafter ( after 96 hours).
|